PubRank

L M Bierer

Author PubWeight™ 16.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry 1996 1.52
2 Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res 1992 1.45
3 Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res 2001 1.33
4 Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992 1.33
5 Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am J Psychiatry 2000 1.24
6 Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch Neurol 1992 0.97
7 Effortful and automatic cognitive processes in depression. Arch Gen Psychiatry 1986 0.90
8 Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 1993 0.87
9 Galanin-like immunoreactivity is increased in the postmortem cerebral cortex from patients with Alzheimer's disease. J Neurochem 1994 0.85
10 L-deprenyl and physostigmine for the treatment of Alzheimer's disease. Psychiatry Res 1995 0.79
11 Cortical cholinergic markers in schizophrenia. Schizophr Res 1994 0.78
12 Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease. Biol Psychiatry 1995 0.78
13 Neurofibrillary tangles, Alzheimer's disease and Lewy bodies. Lancet 1990 0.78
14 Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neurosci Lett 1993 0.77
15 Combined administration of physostigmine and clonidine to patients with dementia of the Alzheimer type: a pilot safety study. Alzheimer Dis Assoc Disord 1989 0.76
16 Cholinergic strategies in the treatment of Alzheimer's disease. Acta Psychiatr Scand Suppl 1991 0.75
17 Platelet phospholipid synthesis in Alzheimer's disease. Neurobiol Aging 1991 0.75
18 Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease. Biol Psychiatry 1995 0.75
19 The dexamethasone suppression test in panic disorder: comparison with normal controls. Biol Psychiatry 1985 0.75
20 Caffeine-induced escape from dexamethasone suppression. Arch Gen Psychiatry 1985 0.75